Long-acting Beta-agonists Market Share

On the basis of geographical analysis, the global long-acting beta-agonists market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Asia Pacific industry is expected to hold largest revenue share by 2036, driven by high prevalence of COPD, bronchospasm, and other disorders amongst the geriatric population. Further, asthma and other respiratory diseases are more common amongst the pediatric and geriatric population. The high population of older adults and children in the APAC region is estimated to boost the market growth.  

The market in the North America region is anticipated to gain the largest market share throughout the forecast period owing to the high incidences of asthma amongst children. As per the data by the Center for Disease Control and Prevention (CDC), 6 million children below 18 years have asthma, in the U.S.